Cartesian Therapeutics (RNAC) Prepaid Assets (2015 - 2026)

Cartesian Therapeutics (RNAC) has 12 years of Prepaid Assets data on file, last reported at $3.1 million in Q1 2026.

• On a quarterly basis, Prepaid Assets rose 7.39% year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $3.1 million, a 7.39% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, down 3.88% from the prior year.
• Prepaid Assets for Q1 2026 stood at $3.1 million, up from $3.0 million in the prior quarter.
• Over the last five years, Prepaid Assets for RNAC reached as high as $6.5 million in Q2 2022 and fell as low as $2.0 million in Q2 2024.
• Historically, Prepaid Assets has averaged $3.9 million across 5 years, with a median of $3.5 million in 2023.
• Across the five-year window, Prepaid Assets slumped 52.0% in 2024 and jumped 32.93% in 2025, its largest moves.
• Year by year, Prepaid Assets stood at $3.8 million in 2022, then jumped by 31.47% to $5.0 million in 2023, then plunged by 36.7% to $3.1 million in 2024, then decreased by 3.88% to $3.0 million in 2025, then increased by 3.81% to $3.1 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $3.1 million in Q1 2026, $3.0 million in Q4 2025, and $3.2 million in Q3 2025.